1. Syvatets M, Tolani K, Zhang M, Tulman G, Charchaflieh J. Intraoperative Management of Deep Hypothermic Circulatory Arrest in Adults Undergoing Aortic Arch Surgery. Journal of Cardiothoracic and Vascular Anesthesia. (In press).
  2. Lee H, Green DJ, Lai L, Hou YJ, Jensenius JC, Liu D, Cheong C, Park CG, Zhang M. Early complement factors in the local tissue immunocomplex generated during intestinal ischemia/reperfusion injury. Mol Immunol. 2010;47(5):972-981.
  3. Chiu IM, Phatnani H, Kuligowski M, Tapia JC, Carrasco MA, Zhang M, Maniatis T, Carroll MC. Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. Proc Natl Acad Sci U S A. 2009;106(49):20960-20965. [Full Text]
  4. Zhang M, Alicot EM, Carroll MC. Human natural IgM can induce ischemia/reperfusion injury in a murine intestinal model. Mol Immunol. 2008;45(15):4036-4039.
  5. Lai L, Lee D, Ko W, Shevde S, Zhang M. Deficiency of complement factor MBL in a patient required cardiac surgery after an acute myocardial infarction with underlining chronic lymphocytic leukemia. Int J Cardiol. 2008;Nov 25.
  6. Zhang M, Carroll MC. Natural antibody mediated innate autoimmune response. Mol Immunol. 2007;44(1-3):103-10. [PubMed]
  7. Zhang M, Carroll MC. Natural IgM-mediated innate autoimmunity: a new target for early intervention of ischemia-reperfusion injury. Expert Opin Biol Ther. 2007;7(10):1575-1582.[link to journal]
  8. Zhang M, Alicot E, Chiu I, Li J, Verna N, Vorup-Jensen T, Kessler B, Shimaoka M, Chan R, Friend D, Mahmood U, Weissleder R, Moore FD and Carroll MC. Identification of the Target Self-antigens in Reperfusion Injury. J Exp Med. 2006; 203:141-52. [Full Text]
  9. Zhang M, Michael LH, Grosjean SA, Kelly RA, Carroll MC, and Entman ML. The role of natural IgM in myocardial ischemia-reperfusion injury. J Mol Cell Cardiol. 2006; 41:62-7. [PubMed]
  10. Zhang M, Takahashi K, Alicot EM, Vorup-Jensen T, Kessler B, Thiel S, Jensenius JC, R. Ezekowitz AB, Moore FD, and Carroll MC. Activation of the lectin pathway by natural IgM in a model of ischemia/reperfusion Injury. J Immunol. 2006;177(7):4727-34. [PubMed]
  11. Chan RK, Verna N, Afnan J, Zhang M, Ibrahim S, Carroll MC, Moore FD, Jr. Attenuation of skeletal muscle reperfusion injury with intravenous 12 amino acid peptides that bind to pathogenic IgM. Surgery. 2006;139:236-43. [PubMed]
  12. Barrington RA, Zhang M, Zhong X, Jonsson H, Holodick N, Cherukuri A, Pierce SK, Rothstein TL, Carroll MC. CD21/CD19 coreceptor signaling promotes B cell survival during primary immune responses. J Immunol. 2005;175(5):2859-67.[PubMed]
  13. Zhang M, Austen WG, Jr., Chiu I, Alicot EM, Hung R, Ma M, Verna N, Xu M, Hechtman HB, Moore FD, Jr., Carroll MC. Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury. Proc Natl Acad Sci U S A. Mar 16 2004;101:3886-91. [Full Text]
  14. McCarthy B. A., Chong SY, Parker G, Meramo M, Zhang M, Czarneski J, Mansour A, Raveche ES. In Vivo and In Vitro Analysis of IL-10 in the NZB Leukemic Model. 2004; Cancer Genomics & Proteomics 1: 407-418 [link to journal]
  15. Gadjeva M, Tomczak MF, Zhang M, Wang YY, Dull K, Rogers AB, Erdman SE, Fox JG, Carroll M, Horwitz BH. A role for NF-kappaB subunits p50 and p65 in the inhibition of lipopolysaccharide-induced shock. J Immunol. 2004;173:5786-93. [PubMed]
  16. Austen WG, Jr., Zhang M, Chan R, Friend D, Hechtman HB, Carroll MC, Moore FD, Jr. Murine hindlimb reperfusion injury can be initiated by a self-reactive monoclonal IgM. Surgery. 2004;136:401-6. [PubMed]
  17. Reid RR, Woodcock S, Shimabukuro-Vornhagen A, Austen WG, Jr., Kobzik L, Zhang M, Hechtman HB, Moore FD, Jr., Carroll MC. Functional activity of natural antibody is altered in Cr2-deficient mice. J Immunol. 2002;169:5433-40. [Full Text]
  18. Zhang M, Chong SY, Raveche ES. The role of B-cell-specific activator protein in the response of malignant B-1 cells to LPS. Exp Cell Res. 2001;264:233-43. [PubMed]
  19. Yen Chong S, Lin YC, Czarneski J, Zhang M, Coffman F, Kashanchi F, Raveche E. Cell cycle effects of IL-10 on malignant B-1 cells. Genes Immun. 2001;2:239-47. [PubMed]
  20. Chong SY, Zhang M, Lin YC, Coffman F, Garcia Z, Ponzio N, Raveche ES. The growth-regulatory role of B-cell-specific activator protein in NZB malignant B-1 cells. Cancer Immunol Immunother. 2001;50:41-50. [PubMed]
  21. Barrington R, Zhang M, Fischer M, Carroll MC. The role of complement in inflammation and adaptive immunity. Immunol Rev. 2001;180:5-15. [PubMed]
  22. Zhang M, Raveche ES. Apoptosis induction in fludarabine resistant malignant B-1 cells by G2- M cell cycle arrest. Oncol Rep. 1998;5:23-30. [PubMed]
  23. Peng B, Zhang M, Sun R, Lin YC, Chong SY, Lai H, Stein D, Raveche ES. The correlation of telomerase and IL-10 with leukemia transformation in a mouse model of chronic lymphocytic leukemia (CLL). Leuk Res. 1998;22:509-16. [PubMed]